Avoid fatty, greasy, or spicy foods
RetaLABS Retatrutide 10mg is the entry-format lyophilised research vial of LY3437943, a triple GLP-1, GIP, and Glucagon receptor agonist developed by Eli Lilly
A meta-analysis [74] including the ELIXA [66], LEADER [44], SUSTAIN-6 [67], EXSCEL [68], REWIND [70], and AMPLITUDE-O [51] studies found that GLP-1RAs were associated with better renal outcomes: a 30% or 40% or more decrease in glomerular filtration rate, need for renal replacement therapy, end-stage renal failure, or death from kidney disease by 21%
This temporarily alters plasma nutrient concentrations without necessarily altering tissue nutrient levels
"It's a very complex discussion
This is not a one size fits all decision